Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cidara Therapeutics

19.44
+0.26001.36%
Post-market: 19.440.00000.00%16:12 EDT
Volume:112.07K
Turnover:2.16M
Market Cap:212.94M
PE:-0.73
High:19.58
Open:19.25
Low:18.69
Close:19.18
Loading ...

Cidara Therapeutics Price Target Maintained With a $35.00/Share by Needham

Dow Jones
·
10 Apr

Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire
·
02 Apr

Elicio Therapeutics Names Preetam Shah CFO

MT Newswires Live
·
24 Mar

Elicio Therapeutics Hires CFO From Cidara Therapeutics

Dow Jones
·
24 Mar

Positive Buy Rating for Cidara Therapeutics Driven by Promising CD388 Development and Safety Profile

TIPRANKS
·
19 Mar

Cidara Therapeutics Announces Publication of CD388 Preclinical Data in Nature Microbiology

GlobeNewswire
·
17 Mar

Cidara Therapeutics initiated with an Outperform at Citizens JMP

TIPRANKS
·
12 Mar

Buy Rating for Cidara Therapeutics: Promising Potential of CD388 in Influenza Prevention

TIPRANKS
·
12 Mar

Cidara Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
10 Mar

Cidara Therapeutics price target raised to $35 from $24 at H.C. Wainwright

TIPRANKS
·
10 Mar

Cidara Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $35 From $24

THOMSON REUTERS
·
10 Mar

Cidara Therapeutics Faces Financial Risks Amid Delayed Annual Report Filing

TIPRANKS
·
08 Mar

Cidara Therapeutics Advances with Strong Financial Backing

TIPRANKS
·
08 Mar

Buy Rating for Cidara Therapeutics Driven by Phase 2b Trial Progress and Strong Financial Position

TIPRANKS
·
07 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
07 Mar

Cidara Therapeutics: Q4 Earnings Snapshot

Associated Press Finance
·
07 Mar

Cidara Therapeutics reports Q4 EPS ($5.37) vs. (71c) last year

TIPRANKS
·
07 Mar

Cidara Therapeutics Q4 2024 GAAP EPS $(5.37) Misses $(3.62) Estimate

Benzinga
·
07 Mar

BRIEF-Cidara Therapeutics Announces Appointment Of Frank Karbe As Chief Financial Officer

Reuters
·
19 Feb

Cidara Therapeutics Inc - Preetam Shah Departs as CFO of Cidara Therapeutics

THOMSON REUTERS
·
19 Feb